Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioPartners

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Owner and operator of a biotechnology company, primarily focusing on the development of drugs and bio-pharmaceuticals. The company's main products include: Valtropin, Interferon beta, Alpheon and Ravanex.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • Sihlbruggstrasse 3
  • 6340 Baar
  • Switzerland

+41 041 000 00 00

BioPartners Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioPartners‘s full profile, request access.

Request full access to PitchBook

BioPartners Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 01-Dec-2004 00000 00000 00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

BioPartners Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BioPartners‘s full profile, request access.

Request full access to PitchBook